Concepedia

Hitoshi Soda

HS

2

Publications

38

Citations

2

H-Index

2012

Active since

Affiliations

Showa University(Current)

Hitoshi Soda is an author at Showa University specializing in public health, medicine, and prognostic biomarkers.

Top concepts

Publications per year

2012–2015

2

Publications

2

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

Hitoshi Soda, Hiromichi Maeda, Junichi Hasegawa et al. · BMC Cancer · 2015 · 27 citations · Full text

[Significance of Onodera's prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy].

Ichirou Okada, Atsushi Shirahata, Hitoshi Soda et al. · PubMed · 2012 · 11 citations

, , +22

Rows per page

1–2 of 2